TC
NWBO

TradeLink Capital’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

TradeLink Capital’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,800
Closed -$13K – 438
2014
Q1 		$13K Buy
+1,800
New +$10.7K 0.02% 221

Other funds holding NWBO

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TradeLink Capital's NWBO Position: Q2 2014 in Review

TradeLink Capital sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q2 2014, closing a stake of 1,800 shares — an estimated $13K sold.

TradeLink Capital first reported a position in NWBO in Q1 2014 and held it in 1 quarter. The position peaked at $13K in Q1 2014. 80 funds tracked by Wall St. Rank hold NWBO as of Q2 2014.

  • TradeLink Capital reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q2 2014 after selling out during the quarter.
  • TradeLink Capital sold 1,800 Northwest Biotherapeutics, Inc. Common stock shares in Q2 2014, an estimated $13K.
  • TradeLink Capital first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q1 2014 and held it in 1 quarter.
  • TradeLink Capital's Northwest Biotherapeutics, Inc. Common stock position peaked at $13K in Q1 2014.
  • 80 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q2 2014.

Based on TradeLink Capital's 13F filing for Q2 2014, filed 31 Jul 2014.